-
Health Care Sector Showing Strength
Monday, June 13, 2011 - 1:28pm | 382The Health Care Sector is the strongest area of the market in today's trading session, currently up 0.5% on the day. The best performing stocks in the S&P 500 Health Care Sector currently are: 1) Forest Laboratories (NYSE: FRX): Shares of Forest Laboratories are currently trading up 1.8% from...
-
LifeTech Capital Maintains Strong Buy on Oculus Innovative Sciences
Monday, June 13, 2011 - 9:13am | 82LifeTech Capital is out with its report today on Oculus Innovative Sciences (NASDAQ: OCLS), maintaining Strong Buy. In a note to clients, LifeTech Capital writes, "We believe shares of Oculus Innovative Sciences are undervalued and are maintaining Oculus with a Strong Buy rating and a 12-18 month...
-
Benzinga's Top Downgrades
Monday, June 13, 2011 - 8:18am | 129Analysts at Robert W. Baird downgraded Fairchild Semiconductor International Inc. (NYSE: FCS) from “outperform” to “neutral.” FCS's shares closed at $16.69 on Friday. FCS' trailing-twelve-month ROA is 7.45%. Analysts at Wunderlich Securities downgraded Nokia Corp (NYSE: NOK) from “buy” to “hold.”...
-
News Summary for June 13, 2011
Monday, June 13, 2011 - 8:15am | 307This is your Benzinga news summary and traders' outlook for Monday, June 13, 2011, covering headlines from the weekend and Monday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading higher as commodities launch into the week at lower prices. However, the U.S...
-
ViroPharma Announces Nine Abstracts Relating to Cinryze Data Presented at 30th Congress of the EAACI
Monday, June 13, 2011 - 8:09am | 152ViroPharma Incorporated (NASDAQ: VPHM) today announced that data relating to Cinryze® from nine accepted abstracts were presented as poster presentations at the 30th Congress of the European Academy of Allergy and Clinical Immunology, June 11 through 15, in Istanbul, Turkey. Of the nine posters...
-
Citi Raises Endo Pharmaceuticals Estimates
Monday, June 13, 2011 - 7:36am | 119Citi is raising its estimates on Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) on the following elements: “1) An earlier acquisition close,” Citi writes. “2) A lower blended rate on debt (4.4% vs. prior 5.0% est.); 3) $400M retirement in existing Term A loans (TLA); 4) $170M smaller use of...
-
Forest Laboratories Receives Notice of Director Nominations; Icahn Intention To Nominate Four Individuals For Election
Monday, June 13, 2011 - 7:34am | 335Forest Laboratories, Inc. (NYSE: FRX) today announced that it has received notice from High River Limited Partnership, an entity affiliated with Carl C. Icahn, of its intention to nominate four individuals for election to Forest's nine-member Board of Directors at the Company's 2011 Annual Meeting...
-
Oppenheimer Raises PT On Optimer Pharmaceuticals To $19
Monday, June 13, 2011 - 7:31am | 26Oppenheimer has raised the price target on Optimer Pharmaceuticals (NASDAQ: OPTR) from $17 to $19 and maintains its Outperform rating.
-
UPDATE: Piper Jaffray Downgrades Somaxon Pharmaceuticals to Neutral
Monday, June 13, 2011 - 7:29am | 142Piper Jaffray is out with its report today on Somaxon Pharmaceuticals (NASDAQ: SOMX), downgrading SOMX from Overweight to Neutral. In a note to clients, Piper Jaffray writes, "We are downgrading Somaxon to a Neutral from an Overweight and lowering our price target to $2.50 from $5. Though we still...
-
Piper Jaffray Downgrades Somaxon Pharmaceuticals To Neutral, Lowers PT To $2.50
Monday, June 13, 2011 - 6:00am | 28Piper Jaffray has downgraded Somaxon Pharmaceuticals (NASDAQ: SOMX) from Overweight to Neutral and has lowered the price target from $5 to $2.50.
-
Big Name Health Care Stocks Plunging
Friday, June 10, 2011 - 3:48pm | 288The Health Care Sector is one of the worst performing areas of the market in today's session, currently down 1.3%. Some of the worst performing Health Care stocks right now are: 1) Pfizer (NYSE: PFE): Shares of Pfizer are currently trading down 2.9% from yesterday's close to $20.16. The stock has...
-
Options Brief: Elan Corporation, plc
Friday, June 10, 2011 - 1:04pm | 87Shares of Elan Corporation, plc (NYSE: ELN) are higher on the session by 0.78%, trading at $10.36. Overall call volume is now running at 2.01x the daily average, with 59% of all calls traded being purchases on the offer. 6,723 contracts have traded on the session so far. Elan Corporation, plc is...
-
Options Brief: Sanofi-Aventis
Friday, June 10, 2011 - 10:53am | 80Shares of Sanofi-Aventis (NYSE: SNY) are lower on the session by 2.47%, trading at $37.06. Overall put volume is now running at 3.26x the daily average, with 6% of all puts traded being purchases on the offer. 3,202 contracts have traded on the session so far. Sanofi-Aventis is a pharmaceutical...
-
Goldman Sachs Closes Out Two Losing Trades
Friday, June 10, 2011 - 9:33am | 192Goldman Sachs is out with a research note this morning, where it issues closing trade alerts for Johnson & Johnson (NYSE: JNJ) and Vertex Pharmaceuticals (NASDAQ: VRTX). The analysts recommend that investors close out their trade recommendation to buy the $67.50 July calls in Johnson &...
-
J.P. Morgan Maintains Overweight on Forest Laboratories
Friday, June 10, 2011 - 8:46am | 141J.P. Morgan is out with its report today on Forest Laboratories (NYSE: FRX), maintaining Overweight. In a note to clients, J.P. Morgan writes, "Following the approval of Daliresp and the acquisition of Viibryd earlier this year and ahead of FDA filings for linaclotide and aclidinium as several...